Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Chembio Diagnostics Inc    CEMI

CHEMBIO DIAGNOSTICS INC

(CEMI)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

CHEMBIO DIAGNOSTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/25/2019 | 04:39pm EDT

Item 5.07 Submission of Matters to a Vote of Security Holders.

We held our 2019 Annual Meeting of Stockholders on June 18, 2019. The board of directors solicited proxies pursuant to a proxy statement that we filed on April 30, 2019 with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934, as amended on May 1, 2019 and May 8, 2019. There was no solicitation in opposition to the board's solicitation.

At the meeting, holders of common stock were asked to consider and vote upon the five proposals set forth below. Each share of common stock was entitled to one vote with respect to each matter submitted to a vote at the meeting. Shares of common stock representing 15,888,537 votes, or 92.56% of the total votes attributable to all outstanding shares of common stock, were present in person or by proxy at the meeting.

The voting results reported below are final.

The matters considered and voted on by the stockholders at the meeting and the votes of the stockholders were as follows:

Proposal 1. Stockholders voted as follows with respect to the election of each of

            the nominees for director identified in the proxy statement:


Nominee For Withhold Broker Non-Votes Katherine L. Davis 6,173,474 2,227,425 7,487,638 Gail S. Page 6,190,520 2,210,379 7,487,638 Mary Lake Polan 6,489,046 1,911,853 7,487,638 John G. Potthoff 6,462,641 1,938,258 7,487,638 John J. Sperzel III 6,939,794 1,461,105 7,487,638

As a result of this vote, each of the five nominees was elected as a director to serve until the 2020 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified.

Proposal 2. Stockholders approved the Chembio Diagnostics, Inc. 2019 Omnibus

            Incentive Plan, by the following vote:



                               For         Against       Abstain    Broker Non-Votes
Approval of Chembio
Diagnostics, Inc. 2019      7,711,471      680,953        8,475        7,487,638
Omnibus Incentive Plan


Proposal 3. Stockholders ratified the appointment of BDO USA, LLP as independent

            auditor for the fiscal year ending December 31, 2019, by the
            following vote:



                               For         Against       Abstain    Broker Non-Votes
Ratification of
appointment of BDO USA,    15,608,218      240,504       39,815            -
LLP



Proposal 4. Stockholders approved, on a non-binding advisory basis, the

            compensation paid to our executive officers in 2018, as disclosed in
            the 2019 proxy statement, by the following vote:



                               For         Against       Abstain    Broker Non-Votes
Advisory vote on 2018       6,210,052     1,679,771      511,076       7,487,638
executive compensation



Proposal 5. Stockholders voted, on a non-binding advisory basis, to hold an

            advisory vote on executive compensation annually, by the following
            vote:



                            1 Year    2 Years    3 Years    Abstain   Broker Non-Votes
Advisory vote on
frequency of future       8,207,500    67,284     34,092     92,023      7,487,638
advisory votes


--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CHEMBIO DIAGNOSTICS INC
06/27Chembio Diagnostics Receives CE Mark for its Point-of-Care Multiplex Test for..
GL
06/25CHEMBIO DIAGNOSTICS, INC. : Submission of Matters to a Vote of Security Holders ..
AQ
05/29CHEMBIO DIAGNOSTICS, INC. : Regulation FD Disclosure, Financial Statements and E..
AQ
05/08CHEMBIO DIAGNOSTICS : Announces Approval of Dengue Point-of-Care Test by Brazils..
AQ
05/07Chembio Diagnostics Announces Approval of Dengue Point-of-Care Test by Brazil..
GL
05/02CHEMBIO DIAGNOSTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIO..
AQ
05/01CHEMBIO DIAGNOSTICS, INC. : Results of Operations and Financial Condition, Finan..
AQ
05/01CHEMBIO DIAGNOSTICS : Reports First Quarter 2019 Financial Results
AQ
04/22Chembio Diagnostics to Report First Quarter 2019 Financial Results on May 1, ..
GL
04/10CHEMBIO DIAGNOSTICS : Announces Approval of Zika, Dengue and Chikungunya Point-o..
AQ
More news